Literature DB >> 11498745

Gastroparesis following bone marrow transplantation.

D A Eagle1, V Gian, G Y Lauwers, J C Manivel, J S Moreb, S Mastin, J R Wingard.   

Abstract

Patients often develop nausea, vomiting and bloating after bone marrow transplantation (BMT). These symptoms may interfere with nutrition and the ability to take oral medications. Gastroparesis is a recognized cause of these symptoms in non-transplant patients but less is known about patients who undergo BMT. Between January 1996 and March 1997, a total of 151 patients underwent BMT. Eighteen patients (12%) developed persistent symptoms suggestive of gastroparesis (persistent nausea, vomiting or bloating). Scintigraphic gastric emptying studies were performed to assess for gastroparesis. Prokinetic agents were administered at the time of study. The records on these patients were compared with those of all other patients undergoing BMT during the same time period without these symptoms. Nine patients who demonstrated delayed gastric emptying were further evaluated with esophagastroduodenoscopy and biopsy. Biopsy samples were reviewed for evidence of graft-versus-host disease (GVHD). Fourteen of 18 patients demonstrated delayed gastric emptying and most responded to prokinetic agents given at the time of study. Age, conditioning regimen, cytomegalovirus antigenemia and acute GVHD did not appear to be associated with the development of gastroparesis. Allogeneic BMT recipients were at higher risk than autologous BMT patients (26% vs 0%, P < 0.0001). of allogeneic bmt recipients, there was a nonsignificant trend of patients receiving tacrolimus to be less likely to experience gastroparesis than those receiving cyclosporine (27% vs 48%, P = 0.08). For the nine patients undergoing upper endoscopy, GVHD on gastric biopsy was an uncommon finding and was mild when present. Gastroparesis appears to be a common cause of nausea, vomiting and bloating following allogeneic BMT. This may occur less often with tacrolimus than cyclosporine because of the former agent's prokinetic properties. Patients usually respond to prokinetic drugs at the time of scintigraphy. GVHD and CMV infection do not appear to be major contributing factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498745     DOI: 10.1038/sj.bmt.1703084

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Gastroparesis as a significant gastrointestinal adverse event during intensive chemotherapy for solid caner: a case report.

Authors:  Tomohiro Nakayama; Koji Haratani; Takashi Kurosaki; Kaoru Tanaka; Kazuhiko Nakagawa
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

2.  Gastroparesis after living-donor lobar lung transplantation: report of five cases.

Authors:  Fengshi Chen; Yuji Nakamoto; Takeshi Kondo; Tetsu Yamada; Masaaki Sato; Akihiro Aoyama; Toru Bando; Hiroshi Date
Journal:  Surg Today       Date:  2014-01-31       Impact factor: 2.549

3.  Accidental Overdose of Oral Cyclosporine in Haematopoietic Stem Cell Transplantation: A Case Report and Literature Review.

Authors:  Ali Tafazoli
Journal:  Drug Saf Case Rep       Date:  2015-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.